Format

Send to

Choose Destination
N Engl J Med. 2002 Feb 28;346(9):683-93.

Imatinib mesylate--a new oral targeted therapy.

Author information

1
Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Comment in

PMID:
11870247
DOI:
10.1056/NEJMra013339
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center